Vanberra Signal

PredictCan Biotechnologies

Curated by Signal

Provider of AI-based system for precision medicine in oncology

Overview

Provider of AI-based system for precision medicine in oncology. It offers cell reprogramming technology to detect precancerous signals for cancer detection and a 3D system for clinical trial of personalized cancer therapy.

Key facts

Founded
2021
Headquarters
Grabels, France

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of hemp-based wellness products to manage health

    Health TechnologyVaux le Penil, France
  • Provider of AI-based software for the healthcare industry

    Health TechnologyParis, France
  • Online platform for the purchase of personalized hearing aids

    Health TechnologyParis, France

About PredictCan Biotechnologies

What does PredictCan Biotechnologies do?

Provider of AI-based system for precision medicine in oncology.

Where is PredictCan Biotechnologies headquartered?

PredictCan Biotechnologies is headquartered in Grabels, France.

When was PredictCan Biotechnologies founded?

PredictCan Biotechnologies was founded in 2021.

Which sector is PredictCan Biotechnologies in?

PredictCan Biotechnologies operates in Health Technology.

Who are PredictCan Biotechnologies's competitors?

Companies similar to PredictCan Biotechnologies include Naturicious, Quaefacta, and GrandAudition.